Published online Feb 27, 2012. doi: 10.4240/wjgs.v4.i2.36
Revised: October 26, 2011
Accepted: November 10, 2011
Published online: February 27, 2012
AIM: To determine the long-term results of choledochodudenostomy in patients with benign billiary obstruction.
METHODS: This prospective study was conducted at Sheri Kashmir Institute of Medical Sciences Srinagar Kashmir, India over a period of 10 years from January 1997 to December 2007. The total number of patients who underwent choledochoduodenostomy during this period was 270. On the basis of etiology of biliary tract obstruction, patients were divided into a calculus group, an oriental cholangiohepatitis group, a benign biliary stricture group and others. Patients were followed for a variable period of 13 mo to 15 years.
RESULTS: Choledochoduodenostomy (CDD) with duo-denotomy was performend in four patients. CDD with removal of T- tube, CDD with left hepatic lobectomy and CDD with removal of intra biliary ruptured hydatid was performed in three patients each. In the remaining patients only CDD was performed. Immediate post operative complications were seen in 63 (23%) patients, while long-term complications were seen in 28 (11%) patients, which were statistically significant. Three patients died during hospitalization while four patients died in the late post-operative period.
CONCLUSION: Our conclusion is that CDD is safe and produces good long term results when a permanent biliary drainage procedure is required.
- Citation: Malik AA, Rather SA, Bari SU, Wani KA. Long-term results of choledochoduodenostomy in benign biliary obstruction. World J Gastrointest Surg 2012; 4(2): 36-40
- URL: https://www.wjgnet.com/1948-9366/full/v4/i2/36.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v4.i2.36
Choledochoduodenostomy (CDD) has been the subject of considerable controversy since its first description by Riedel in 1892. Its acceptance is still debated in view of the expected complications, such as ascending cholangitis, sump syndrome and alkaline reflux gastritis. In spite of the good long-term results observed in some studies, CDD is considered a last resort for lower common bile duct (CBD) obstruction. The common indications for CDD have remained unchanged over the years and also have dominated our series. These are choledocholithiasis, lower bile duct strictures, worm obstruction, papillary or ampullary stenosis, perivaterian diverticuli. In the modern era of endoscopy a significant number of patients still need surgical intervention for benign billiary duct obstruction but as repeated interventions on the CBD lead to increased morbidity and mortality, a permanent drainage procedure is indicated in all such patients. The present study was conducted to evaluate the effectiveness of CDD in preventing the need for repeated exploration and the occurrence of long-term complications.
The prospective study was conducted at Sheri Kashmir Institute of Medical Sciences Srinagar Kashmir, India over a period of 10 years from January 1997 to December 2006, upon patients who underwent choledochoduodenostomy. The study comprised 270 patients (99 males and 171 females) of 20 to 70 years of age. Forty two patients were lost to follow up. The remaining 232 patients formed the database of this analysis.
All patients were subjected to baseline investigations which included haemogram kidney function tests, liver function tests and coagulogram. Abdominal sonography and endoscopic retrograde cholangiopancreatography (ERCP) were the most common investigation tools. Computerised tomography and magnetic resonance cholangiopancreaticography were used when indicated. On the basis of pre-operative diagnosis and intra-operative findings, patients were divided into four groups (Table 1). These were the Calculus group where ERCP had failed to clear the common bile duct of stones, the Oriental cholangiohepatitis group (separately categorized because of different course of the disease process), the benign biliary Stricture group and the others (including cases of biliary ascariasis, intra-biliary rupture of hydatid liver, chronic pancreatitis, and portal hypertension with CBD stone.
No. | Presentation | Male | Female | Total | |||
n | % age | n | % age | n | % age | ||
1 | Calculus group | 41 | 15.18 | 92 | 34.07 | 133 | 49.26 |
2 | OCH group | 39 | 14.44 | 42 | 15.55 | 81 | 30.00 |
3 | B.B. Strictures/ligatures2 | 9 | 03.33 | 17 | 06.29 | 26 | 09.63 |
4 | Others | 10 | 03.70 | 20 | 07.40 | 30 | 11.11 |
Total | 99 | 36.66 | 171 | 63.33 | 270 | 100 |
Chi square test was used for statistical evaluation.
Side-to-side choledochoduodenostomy is the procedure of choice for all indications except iatrogenic injuries and the controversial indication of malignant obstruction. Complete circumferential division of the common bile duct or the common hepatic duct compromises the blood supply to both ends of the duct and may predispose the anastomosis to an ischemic stricture. After the cholecystectomy is carried out, the duodenum and pancreas are mobilized by an extensive Kocher manoeuvre. The common bile duct is exposed by incising the overlying peritoneum. The common bile duct is opened longitudinally with a scalpel at the supraduodenal location, extending proximally for 2 to 2.5 cm. Any manipulations such as removal of any stone, worms or biopsy are completed at this point. After common bile duct exploration and proper mobilization and exposure have been achieved, a longitudinal incision is made in the post bulbar duodenum using cautry for a distance of approximately 1.5 cm. A single layer anastomosis using 3-0 Vicryl is accomplished by beginning posteriorly and positioning the knots on the outside of the anastomosis. The anterior portion of anastomosis is performed using simple interrupted sutures. A closed suction drain is placed in the area of anastomosis but not in direct contact with it. The drain is removed on the fourth post-operative day.
The patients were followed up 6 weekly for first three months, quarterly for the following nine months, biannually for the next two years and annually thereafter.
Follow up was for an average period of 8.25 years (ranging from 13 mo to 13 years). During follow up visits investigations were guided by comprehensive history and clinical examination including liver function test, abdominal sonography, gastroduodenoscopy and biliary scintigraphy. Deworming of the patients was a final and important component of our follow up. The final outcome of the patients was recorded and systematically arranged for evaluation.
In our study of 270 patients there was not much difference in the mean ages of the patients of the two sexes: 47.12 ± 12.61 in males, 44.92 ± 13.83 in females (P > 0.05).
Among the clinical features, pain was the most consistent symptom in all cases (100%) followed by fever/rigors (50%), vomiting (43%), jaundice (33%). At the time of presentation 53.33% of the patients had serum bilirubin less than 1.3 mg%, and only 11.8% of the patients had levels above 10 mg%. Serum alkaline phosphatase was raised in 92.22% of the patients, and was normal in only 7.78%.
The size of CBD varied from 2 to 3 cm in our series. CDD with duodenotomy was required in 4 patients for impacted stones at the lower end of CBD. CDD with removal of T-tube, CDD with (L) Hepatic Lobectomy and CDD with Removal of intra-biliary ruptured hydatid was performed in three patients each. Redo-CDD was carried out in two patients, one each from oriental cholangiohepatitis (OCH) and Calculus groups, who had undergone CDD three and seven years earleir, respectively. Redo-CDD was performed in these patients, instead of CBD exploration only, because of the presence of distal stricture. The operative technique in redo-CDD was same as was used in other patients. All patients with OCH had undergone unsuccessful endoscopic treatment before surgery.
As shown in Table 2, 63 patients (23.33%) across all four groups developed immediate post-operative complications. This was statistically insignificant (P > 0.05). Long-term complications were seen in 28 (11%) patients (Table 3). No case of sump syndrome, recurrent/residual calculi or biliary ascariasis was recorded. On long-term follow up patients were classified on the basis of symptomatology and investigations of the four groups can be seen in Table 4.
Complications | Calculusgroup | OCH group | Stricture group | Others group | Total | P value |
Wound | ||||||
Infection | 9 (6.76) | 6 (7.4) | 1 (3.84) | 1 (3.33) | 17 (6.2) | > 0.05 |
Dehiscence | - | - | - | 1 (3.33) | 1 (0.3) | > 0.05 |
Hernia | 1 (0.7) | - | - | - | - | > 0.05 |
Post-op. fever | 5 (3) | 10 (12) | 1 (3) | 1 (3) | 17 (6) | > 0.05 |
Septicaemia | - | 4 (5) | 1 (3) | 2 (6) | 7 (3) | > 0.05 |
Pulmonary | ||||||
Atelectasia | 6 (4) | 3 (3) | 2 (7) | 1 (3) | 12 (4) | > 0.05 |
Pneumonia | 1 (0.75) | 2 (2) | - | - | 3 (1) | > 0.05 |
Peritoneal | ||||||
Haemorrhage | - | - | - | - | - | |
Bile drainage | 1 (0.75) | 2 (2) | 1 (3) | - | 4 (2) | > 0.05 |
Cardiovascular | - | - | - | - | - | |
MI | - | - | - | - | - | |
Arrhythmia | - | 2 (2) | - | - | 2 (0.74) | > 0.05 |
Total | 63 (23.3) | NS |
Complications | CalculusGroup n = 106 | OCH group n = 81 | Stricture group n = 22 | Others group n = 16 | Total | P value |
Alkaline gastritis | 6 (5.67) | 4 (5.4) | 1 (4.5) | - | 11 (4.88) | > 0.05 |
Cholangitis | - | 5 (6.8) | 1 (4.5) | 1 (3.84) | 7 (3) | > 0.05 |
Liver abscess | - | 3 (3.7) | - | - | 3 (1) | > 0.05 |
Stenosis of anastomosis | 1 (0.96) | - | 1 (4.5) | - | 2 (0.8) | > 0.05 |
Results | Patient complaint | Ultrasonography | Liver function test | EGD | HIDA scan | Total |
Excellent | None | Normal | Normal | - | - | 116 (51.55%) |
Good | Occasionally dyspeptic | Normal | Normal | +/- | - | 93 (41.33%) |
Moderate | Evident dyspepsia, nausea, bilious vomiting or fever rigours | Normal or IHD dilated | Normal or slightly deranged | Alkaline gastritis | Patent anastomosis evidence of gastric reflux | 11 (4.88%) |
Bad | Septecemia/cholangitis, anastomotic stenosis | Liver abscesses | Grossly deranged | +/- | Patent anastomosis, dilated IHD with slow transit | 5 (2.22%) |
As shown in Table 5, 3 patients died during their hospitalization, due to septicaemia and its complications in all cases. Four patients died in the late post-operative period, including 3 patients from the OCH group who had developed liver abscess on long-term follow up and died of the same. Thus the overall mortality was 2.59%.
No. | Age ( yr) | Sex | Time | Initial daignosis | Cause of death |
1 | 55 | M | 1st POD | Suppurative cholangitis | Septic shock/DIC |
2 | 32 | F | 2nd POD | Biliary peritonitis | Septicaemia with arrhythmia |
3 | 65 | M | 12th POD | Infected liver hydatid with intra-biliary rupture | Wound dehiscence with septicaemia with ARDS |
4 | 54 | M | 8 mo | OCH with right lobe liver abscess with cholangitis | Septicaemia with MODS |
5 | 46 | F | 13 mo | OCH with multiple liver abscess | Septicaemia with MODS |
6 | 58 | F | 15 mo | Suppurative cholangitis | Arrhythmia |
7 | 45 | M | 10 yr | OCH with multiple liver abscess with sepsis | Septicaemia with MODS |
The historical development of choledochoduodenostomy was summarized by Madden and associates in 1970. The review of the relevant literature and the observations of the present study suggest that the indications for CDD remain very much the same as those detailed by Degenshein[1] in 1974 (except for the malignant ones). CDD has been recommended in the treatment of multiple calculi of the common bile duct, retained or residual stones, hepatic stones, distal common bile duct strictures, ampullary stenosis, benign ampullary tumours[1], primary duct stones, recurrent common duct stones, dilated CBD with diameter greater than 20 mm, failure of ERCP, non-availability of ERCP[2-6]. While CDD is particularly recommended for use in elderly patients[7], it is also recommended in younger patients since a more aggressive therapy may be indicated in their often “more aggressive lithogenic diathesis”[8]. Choledocholithiasis (primary/secondary, retained/residual, recurrent or impacted) remains the sole indication in our series (49.26%) and none of the patients developed recurrent or residual stones,making CDD highly recommendable for such patients. There are some patients where CDD is contraindicated. These include patients with CBD less than 15 mm in diameter, perivaterian diverticulum and sclerosing cholangitis.
OCH was the next most common indication for CDD in our series (30%, i.e., 81 patients). This was expected as out Institute is in a high prevalence zone of the disease. This poses a challenge to the surgeons to treat these cases effectively. We subjected 3 patients to CDD with left hepatic lobectomy for hepatolithiasis and atrophied lobe. In the remaining 78 patients CDD was performed after the stones and debris had been removed. Of these patients 10% developed solitary/multiple liver abcesses, probably by the development of new proximal strictures/stones making the draining anastomosis less efficient. Recently, Tang et al[9] used laproscopic choledochoduodenostomy (LCD) as an effective drainage procedure in 12 patients with recurrent pyogenic cholangitis. There was no recurrence of cholangitis or any evidence of sump syndrome in these patients.
The principal aim of this study was to analyze the results obtained with CDD in patients followed for 1-13 years and to determine the safety of this operation even at the extremes of age. We experienced 3 (1.11%) early post-operative deaths due to suppurative cholangitis or billiary peritonitis. There were 4 (1.77%) late deaths (between 8 mo to 10 years) during the long- term follow up. Although a mortality rate of less than 1% has been reported for CDD7, the average mortality rate is 2%-5% and can be much higher[1,2,4,10]. The morbidity of CDD observed in our study (23.33%) as well as the type of observed complications, parallels those previously reported in the literature. Perhaps the most important aspect of our study is absence of sump syndrome and interestingly, biliary ascariasis. Sump syndrome is a rare and late complication of side-to-side CDD. Its prevalence has long remained uncertain and has been reported to vary between 0% and 9.6%[4,8,11]. Based on our observations, three factors could explain the absence of this complication in our series in spite of side-to-side anastomosis being used in all the cases. First, a sump with wide anastomosis provides effective drainage of food debris that enters the bile duct. Second, the lower aspect (sump) of the anastomosis is usually narrow and this prevents the entry and impaction of food debris in the sump segment. A third important factor was the pre-operative ERCP which was carried out in 89.25% of patients in which wide papillotomy was made in most cases, thereby arresting this complication before it occurred.
Our study was conducted in a zone of high endemic ascariasis in which the surgeons created a biliary-enteric anastomosis with an inherent risk of worm migration into the biliary radicals. To contain this risk the patients were advised to take regular antihelminthic drugs at intervals of 3-4 mo to keep their intestinal worm load to the minimum. Interestingly, even those patients who did not comply with this regime did not show any increased incidence of biliary ascariasis, This was probably because a wide gateway created allows the worms to pass easily in either direction without getting stuck, thus avoiding the pathogenesis of biliary ascariasis and its complications. However, further studies are needed to confirm this. On long-term follow up we observed alkaline reflux gastritis in 4.88% of the patients. These patients were treated effectively by ursodeoxycholicacid (dose 300 mg BD for 10-14 d). Mihmanli et al[12] noticed a higher incidence of alkaline reflux gastritis in their series (20.8%). In our series of 225 patients the incidence of cholangitis observed was low, at 3.11%, (7 patients of whom 5 were from the OCH group), possibly explained by the progressive nature of the disease in the proximal hepatobiliary segments. Escudero-Fabre et al[13] reported proved cholangitis in 4.2% of cases. In the clinical classification of the patients, according to the results from the long-term analysis, the “Good” and “Excellent” were predominant, with 93 patients (41.33%) in the former group and 69 patients (30.66%) in the latter. The “Moderate” group of 48 patients (21.33%) included patients with evident dyspepsia, nausea, bilious vomiting (alkaline gastritis) or fever and rigors (cholangitis). We had 15 patients (6.66%) in the “Bad” category, all of whom had cholangitis/septicemia and liver abcess(es) and most of whom were from the OCH group. Mihmanli et al[12] observed 75% of CDD patients in excellent or good category and the remaining 25% in moderate category. Bhandarkar et al[14] observed that LCD is a safe and effective option in patients with stones in a dilated bile duct when endoscopic clearance has failed. Tang et al[9] selected twelve patients with diagnosis of recurrent pyogenic cholangitis with the absence of intrahepatic stricture for laparoscopic choledochodudenostomy during the period from 1995 to 2002. The majority of patients had repeated attacks of cholangitis and had already undergone multiple sessions of endoscopic and operative lithotripsy. The laparoscopic choledochoduodenostomy was performed using a five-port approach with the patient lying in the supine position. The stones were first cleared through the longitudinal supraduodenal choledochotomy followed by construction of a side-to-side diamond-shaped anastomosis of at least 15 mm between the bile duct and the first part of the duodenum using 2/0 monocryl in the single-layer method. The median operation time was 137.5 min (90-270) and the median postoperative stay was 7.5 d (5-20 d). Average analgesic requirement post operation was 126 mg (50-200 mg) intramuscular pethidine. There was one postoperative bile leak, and this complication was resolved by conservative measures. Upon a mean follow up of 37.6 mo (6-91 mo), there was no recurrent attack of cholangitis or any evidence of sump syndrome in this group of patients. The authors concluded that laparoscopic choledochoduodenostomy is a safe and effective drainage procedure for patients with RPC. Complications are uncommon and postoperative results are promising.
In conclusion, a number of inferences can be drawn from the observations made in this study. CDD produces, both in elderly high risk patients and in younger ones with a longer life expectancy, good long term results in the treatment of benign biliary tract obstruction when a permanent biliary drainage procedure is required. However, the size of the CBD is of critical importance and should be at least 15 mm in diameter. Meticulous and precise suturing techniques are also essential. If these precautions are observed, cholangitis and symptoms related to sump syndrome are absent or occur very infrequently. While CDD is not the ideal procedure for OCH patients who rather need a multidisciplinary approach, it is the operation of choice in benign biliary tract obstruction.
Choledochoduodenstomy (CDD) has been performed for a variety of diseases of the biliary tract and pancreas.
CDD has been recommended in the treatment of multiple calculi of the common bile duct (CBD), retained or residual stones, hepatic stones, distal common bile duct strictures, ampullary stenosis, benign ampullary tumours, primary duct stones, recurrent common duct stones, dilated CBD with diameter more than 20 mm, failure of endoscopic retrograde cholangiopancreatography (ERCP), non-availability of ERCP. The principal aim of this study was to analyze the results obtained with CDD and to determine the safety of this operation even in the extremes of age.
While CDD is recommended as a treatment modality in elderly patients, it is also recommended in younger patients since a more aggressive therapy may be indicated in their often more aggressive lithogenic diathesis.
Although, sometimes replaced by endoscopic papillotomy or sphincterotomy, there remain situations where surgical therapy is required.
The authors have conducted the present study to evaluate the effectiveness of CDD in preventing the repeated exploration and occurrence of long-term complications in patients with common bile duct obstruction. The results are interesting and may form the basis of further study.
Peer reviewer: Theodoros E Pavlidis, MD, PhD, Professor, Department of Surgery, University of Thessaloniki, Hippocration Hospital, A Samothraki 23, Thessaloniki 54248, Greece
S- Editor Wang JL L- Editor Hughes D E- Editor Li JY
1. | Degenshein GA. Choledochoduodenostomy: an 18 year study of 175 consecutive cases. Surgery. 1974;76:319-324. [PubMed] [Cited in This Article: ] |
2. | CAPPER WM. External choledochoduodenostomy. An evaluation of 125 cases. Br J Surg. 1961;49:292-300. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
3. | Wright NL. Evaluation of the results of choledochoduodenostomy. Br J Surg. 1968;55:33-36. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
4. | Madden JL, Chun JY, Kandalaft S, Parekh M. Choledochoduodenostomy: an unjustly maligned surgical procedure? Am J Surg. 1970;119:45-54. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
5. | Johnson AG, Rains AJ. Prevention and treatment of recurrent bile duct stones by choledochoduodenostomy. World J Surg. 1978;2:487-496. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
6. | Lygidakis NJ. Choledochoduodenostomy in calculous biliary tract disease. Br J Surg. 1981;68:762-765. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
7. | Moesgaard F, Nielsen ML, Pedersen T, Hansen JB. Protective choledochoduodenostomy in multiple common duct stones in the aged. Surg Gynecol Obstet. 1982;154:232-234. [PubMed] [Cited in This Article: ] |
8. | de Almeida AM, Cruz AG, Aldeia FJ. Side-to-side choledochoduodenostomy in the management of choledocholithiasis and associated disease. Facts and fiction. Am J Surg. 1984;147:253-259. [PubMed] [Cited in This Article: ] |
9. | Tang CN, Siu WT, Ha JP, Li MK. Laparoscopic choledochoduodenostomy: an effective drainage procedure for recurrent pyogenic cholangitis. Surg Endosc. 2003;17:1590-1594. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis (0)] |
10. | Stuart M, Hoerr SO. Late results of side to side choledochoduodenostomy and of transduodenal sphincterotomy for benign disorders. A twenty year comparative study. Am J Surg. 1972;123:67-72. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
11. | Baker AR, Neoptolemos JP, Leese T, Fossard DP. Choledochoduodenostomy, transduodenal sphincteroplasty and sphincterotomy for calculi of the common bile duct. Surg Gynecol Obstet. 1987;164:245-251. [PubMed] [Cited in This Article: ] |
12. | Mihmanli M, Isgör A, Erzurumlu K, Kabukcuoglu F, Mihmalli I. Long-term results of choledochoduodenostomy and T-tube drainage. Hepatogastroenterology. 1996;43:1480-1483. [PubMed] [Cited in This Article: ] |
13. | Escudero-Fabre A, Escallon A, Sack J, Halpern NB, Aldrete JS. Choledochoduodenostomy. Analysis of 71 cases followed for 5 to 15 years. Ann Surg. 1991;213:635-642; discussion 643-644. [PubMed] [Cited in This Article: ] |
14. | Bhandarkar DS, Shah RS. Laparoscopic choledochoduodenostomy for retained bile duct stone. J Postgrad Med. 2005;51:156-157. [PubMed] [Cited in This Article: ] |